-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $14

Benzinga·06/26/2025 11:50:54
Listen to the news
Citigroup analyst Yigal Nochomovitz initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $14.